Enterprise Ireland

Galway Biomedical specializes in the development and manufacturing of medical devices, focusing primarily on surgical implants. Their product portfolio spans various clinical fields, including vascular, dental, orthopaedic, urology, and general surgery, contributing to advancements in biomaterial-based medical device implants.

Output Sports Limited is a sports technology company based in Dublin, Ireland, established in 2018. The company specializes in developing wearable sensors aimed at optimizing athlete performance. By employing advanced signal processing and machine learning techniques, Output Sports has created an innovative end-to-end solution that assesses various components of athletic performance and monitors training programs using a single wearable device. This tool not only evaluates an athlete's readiness to train but also delivers training biofeedback and facilitates injury management. As a result, sports practitioners can enhance athlete performance with improved portability, practicality, and accuracy.

LaNua Medical is a medical technology company that develops innovative, image-guided devices for endovascular procedures. Their primary product is a medical device designed to block blood flow in specific segments of veins or arteries, aiding in the treatment of internal bleeding, vascular malformations, and both benign and malignant tumors. This technology enables healthcare professionals to enhance patient outcomes, reduce procedure times, and lower healthcare costs by minimizing hospital stays.

SymPhysis Medical is focused on developing innovative medical technologies aimed at treating chronic diseases, with a particular emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, is a therapeutic device designed for the home management of malignant pleural effusions (MPE), a common complication in late-stage cancer patients. MPE can lead to severe symptoms such as shortness of breath and chest pain, affecting approximately 15% of cancer patients. The releaze device effectively drains excess fluid from the pleural space, utilizing an active component to improve removal efficiency. This technology not only alleviates debilitating symptoms but also makes indwelling pleural catheter treatments more accessible for patients, significantly contributing to their overall well-being.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

Amara Therapeutics is a company focused on enhancing pelvic health for both women and men through a digital therapeutic platform. It leverages evidence-based medicine and behavioral interventions to create safe, convenient, and non-invasive care pathways for patients. The platform facilitates the tracking of patient-specific conditions and treatment strategies while offering pelvic floor muscle training and expert-led education on pelvic and bladder health. By connecting healthcare providers, patients, and peers, Amara Therapeutics aims to improve the care pathway for pelvic health patients, ensuring they receive affordable and effective treatment options.

pHetalSafe is a medical technology company that specializes in the development of an innovative fetal monitoring system. This system measures fetal lactate and pH levels during labor, aiming to more accurately detect fetal distress and hypoxia, conditions that can lead to long-term brain damage in newborns. By providing health workers with valuable data, pHetalSafe's technology enables better-informed clinical decisions, ultimately promoting optimal patient outcomes.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

Biologit is an early-stage technology company focused on enhancing clinical safety and pharmacovigilance through artificial intelligence. The company aims to reduce the costs and complexities associated with monitoring adverse events in drug development and post-market phases. Its primary product is a scientific literature monitoring platform that enables medicinal product license holders, sponsors, patients, healthcare professionals, and scientists to access accurate information regarding the safety, efficacy, and quality of medicinal products. By streamlining the detection of adverse events, Biologit empowers drug safety professionals to maintain the safety of medicines and protect patient health.

Novus Diagnostics is focused on developing an innovative diagnostic device aimed at detecting sepsis. This technology allows for the rapid and automated identification of pathogens present in whole blood samples. By providing results in minutes, Novus Diagnostics empowers healthcare providers to initiate effective treatment for sepsis patients quickly and efficiently. The approach not only enhances patient care but also aims to reduce costs associated with sepsis management.

Signum Surgical Limited is a medical technology company based in Galway, Ireland, founded in 2014 by Eoin Bambury and Moshe Zilversmit. The company specializes in developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the end of the bowel and the skin near the anus. Signum Surgical's primary product is a bio-absorbable implant designed to be used post-surgery, facilitating the closure and healing of the fistula tract. This implant dissolves within the body after treatment and helps prevent reinfection, thereby promoting a faster healing process. The company's focus on addressing the lack of innovation in this area aims to enhance the effectiveness of care for patients suffering from colorectal conditions.

xWave Technologies is a developer of innovative health platforms aimed at enhancing patient outcomes and streamlining health systems. The company's flagship product, xRefer, is recognized as Europe’s first Smart Radiology Referral Platform, created in collaboration with the European Society of Radiology. This platform utilizes artificial intelligence and machine learning technologies to optimize the referral, protocol, and scheduling processes for patients. By leveraging data resources, xWave Technologies seeks to provide predictive and personalized clinical decision support in medical diagnostics, thereby empowering healthcare professionals to make informed decisions and improve the overall efficiency of patient care.

TrojanTrack is a company specializing in biomechanical technology for the equine industry, focusing on injury and movement analysis for horses. Utilizing a smartphone camera, TrojanTrack's innovative system employs deep neural network technology to objectively assess a horse's gait patterns. This analysis helps identify potential issues that could lead to injuries or hinder performance. By enabling users to automatically track crucial data points as the horse moves, the company provides valuable insights that assist in monitoring and improving equine health and performance.

SymPhysis Medical is focused on developing innovative medical technologies aimed at treating chronic diseases, with a particular emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, is a therapeutic device designed for the home management of malignant pleural effusions (MPE), a common complication in late-stage cancer patients. MPE can lead to severe symptoms such as shortness of breath and chest pain, affecting approximately 15% of cancer patients. The releaze device effectively drains excess fluid from the pleural space, utilizing an active component to improve removal efficiency. This technology not only alleviates debilitating symptoms but also makes indwelling pleural catheter treatments more accessible for patients, significantly contributing to their overall well-being.

FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing connected-health technology, specifically a pressure sensing device known as Tight Alright. This device is designed to measure and monitor sub-bandage pressure during compression therapy, which is crucial for treating venous leg ulcers (VLUs). Effective compression is essential; if the pressure is too loose, it fails to provide therapeutic benefits, while excessive pressure can pose serious risks. FeelTect's technology enables users to view live readings and recorded data, facilitating optimal and individualized treatment regimens. By improving the application and maintenance of safe sub-bandage pressure, FeelTect aims to enhance patient outcomes and reduce the associated health-economic burden.

BioSimulytics is a company that specializes in creating AI-powered software tailored for drug researchers in the pharmaceutical industry. Its innovative platform integrates molecular chemistry, quantum physics, and advanced artificial intelligence to enhance the drug development process. By focusing on crystal-structure prediction, BioSimulytics enables researchers to accurately predict stable polymorphs, which significantly improves the speed, certainty, and quality of product data. This technology aims to streamline the development of pharmaceuticals, ultimately supporting researchers in their quest to bring new drugs to market more efficiently.

FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.

Micron AgriTech is a company focused on improving livestock health through innovative diagnostic solutions. They have developed a portable testing kit named Tástáil, which allows farmers and veterinarians to instantly detect parasitic infections in cattle. This on-site testing capability enables users to analyze samples using a machine learning-based app, significantly reducing the time required to obtain results. By facilitating immediate testing and targeted treatment, Micron AgriTech's platform minimizes unnecessary medication, thereby addressing the growing concern of antimicrobial resistance. This approach not only enhances animal welfare but also promotes cost savings and increased productivity for farm owners.

InVera Medical is focused on developing innovative medical devices aimed at treating varicose veins and venous ulcers. The company is creating BioVena™, a less invasive and pain-free treatment option that utilizes the body's natural biological response to address venous diseases. This proprietary technology positions InVera Medical to significantly improve patient outcomes by providing a safer and more effective alternative to existing treatment methods. With only a small fraction of the 120 million individuals suffering from venous disease receiving adequate endovenous treatment annually, InVera Medical seeks to broaden access to effective care for a population largely underserved by current solutions. The company’s advancements are particularly crucial given the high annual costs associated with venous ulcers, which amount to approximately $33 billion for insurers in the US and EU. By targeting the full spectrum of venous disease, InVera Medical aims to enhance the quality of life for patients who have long been limited to ineffective compression bandaging.

FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.

Deciphex Limited, founded in 2017 and headquartered in Dublin, Ireland, specializes in developing digital pathology software applications that leverage artificial intelligence to enhance diagnostic workflows. The company offers two primary platforms: Diagnexia, which facilitates rapid diagnostics by connecting global subspecialty pathologists to address backlogs, and Patholytix Preclinical, designed for optimizing preclinical safety assessments in pharmaceutical research. By automating routine tasks and triaging high-volume, low-complexity samples, Deciphex enables pathologists to concentrate on more complex cases, ultimately improving productivity and patient outcomes. Through its innovative approach, Deciphex is committed to advancing healthcare delivery and therapeutic development.

Output Sports Limited is a sports technology company based in Dublin, Ireland, established in 2018. The company specializes in developing wearable sensors aimed at optimizing athlete performance. By employing advanced signal processing and machine learning techniques, Output Sports has created an innovative end-to-end solution that assesses various components of athletic performance and monitors training programs using a single wearable device. This tool not only evaluates an athlete's readiness to train but also delivers training biofeedback and facilitates injury management. As a result, sports practitioners can enhance athlete performance with improved portability, practicality, and accuracy.

Deciphex Limited, founded in 2017 and headquartered in Dublin, Ireland, specializes in developing digital pathology software applications that leverage artificial intelligence to enhance diagnostic workflows. The company offers two primary platforms: Diagnexia, which facilitates rapid diagnostics by connecting global subspecialty pathologists to address backlogs, and Patholytix Preclinical, designed for optimizing preclinical safety assessments in pharmaceutical research. By automating routine tasks and triaging high-volume, low-complexity samples, Deciphex enables pathologists to concentrate on more complex cases, ultimately improving productivity and patient outcomes. Through its innovative approach, Deciphex is committed to advancing healthcare delivery and therapeutic development.

THEYA Healthcare is a multi-award-winning medical device company that specializes in the design and manufacture of innovative post-surgery garments, particularly for women undergoing breast cancer treatment and other cosmetic surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of post-operative patients. Theya Healthcare's flagship product line features bras made from a unique bamboo fabric that is scientifically proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare products experienced significant improvements in body image and health status, along with reduced pain and discomfort compared to competing products. Since its inception, the company has garnered numerous accolades, highlighting its commitment to enhancing the recovery experience for women after surgery.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013, specializing in solutions for assessing physical function and preventing falls risk in older adults. The company has developed a patented platform that monitors and identifies mobility impairments by categorizing various mobility parameters, including walking, variability, symmetry, transfers, and turning. By comparing patients' mobility scores against population data based on age and gender, Kinesis Health Technologies provides a comprehensive method for evaluating falls risk and assessing gait, mobility, and frailty in a standardized manner. The team behind Kinesis Health Technologies possesses extensive experience in business, marketing, and technology, supported by 12 years of research conducted in Ireland.

The Hamstring Solo is an exercise aid for carrying out hamstring eccentric and concentric exercises.

Nuritas Ltd., established in 2012 and headquartered in Dublin, Ireland, is a biotechnology company specializing in the discovery of bioactive peptides from food sources using artificial intelligence and genomics. The company's proprietary platform combines computational biology with nutritional science to identify and extract health-benefiting components hidden within food, enabling it to create functional foods and cosmetics. Nuritas collaborates with industry partners to co-develop new ingredients, with applications in human and animal nutrition, beverages, dietary supplements, and cosmetics.

Connexicon Medical Ltd., established in 2014 and headquartered in Dublin, Ireland, specializes in the manufacture of medical adhesives and sealants. Its primary products are tissue adhesives designed for both topical and internal applications, including medical adhesives used in topical wound care. These adhesives offer enhanced wound closure strength, a secure microbial barrier protection against common surgical site infection organisms, and durability for days, enabling healthcare professionals to provide effective wound closure solutions.

OncoMark Limited, founded in 2007 and based in Dublin, Ireland, specializes in the discovery and development of diagnostics and therapeutic targets for cancer patients. As a spin-out from University College Dublin, the company focuses on creating companion diagnostic tests that enhance patient stratification in cancer drug development. These tests aid pharmaceutical companies in identifying patients for whom specific drugs are most likely to be effective, thereby improving clinical trial efficiency and success rates. OncoMark's portfolio includes tissue-based biomarker assays and a Biomarker Interpretation Workflow platform that automates various analyses, such as survival assessments and interpretation of immunohistochemistry staining. The company's diagnostic tests cover major cancer types, including breast, colorectal, prostate, and melanoma, and are supported by significant EU research and development funding. Led by CEO Dr. Mairin Rafferty, OncoMark is committed to improving treatment outcomes and quality of life for cancer patients.

GlycoSeLect is a biotechnology company focused on the development and production of Recombinant Prokaryotic Lectins (RPLs), which serve as advanced tools for analyzing and selectively purifying glycosylated biomolecules. Their RPLs are designed for diverse applications within the life sciences, including glycobiology, glycoproteomics, biomarker discovery, biomedical diagnostics, the biopharmaceutical industry, vaccines, and cosmetics. GlycoSeLect's proprietary technology allows for simplified, rapid, and cost-effective production of RPLs through recombinant expression in Escherichia coli, ensuring high purity and consistent performance. The genetically enhanced binding properties of their lectins provide improved specificity and affinity for glycan structures on glycoproteins and other glycosylated molecules, enabling medical professionals to address challenges in biopharma product analysis more effectively. The scalable nature of their production further supports large-scale applications across various sectors.

Nüdest Foods produces natural, on-the-go snack pouches made from 100% fruit puree, Greek-style yogurt, and whole grains. These snacks are free from added sugar, preservatives, artificial flavors or colors, offering consumers a convenient, nutritious option with no 'nasties'.

OncoMark Limited, founded in 2007 and based in Dublin, Ireland, specializes in the discovery and development of diagnostics and therapeutic targets for cancer patients. As a spin-out from University College Dublin, the company focuses on creating companion diagnostic tests that enhance patient stratification in cancer drug development. These tests aid pharmaceutical companies in identifying patients for whom specific drugs are most likely to be effective, thereby improving clinical trial efficiency and success rates. OncoMark's portfolio includes tissue-based biomarker assays and a Biomarker Interpretation Workflow platform that automates various analyses, such as survival assessments and interpretation of immunohistochemistry staining. The company's diagnostic tests cover major cancer types, including breast, colorectal, prostate, and melanoma, and are supported by significant EU research and development funding. Led by CEO Dr. Mairin Rafferty, OncoMark is committed to improving treatment outcomes and quality of life for cancer patients.

Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

Beats Medical is a digital therapeutics company focused on developing technology solutions for chronic neurological disorders, particularly Parkinson's disease. The company offers an innovative app that empowers individuals with Parkinson's to manage their condition more effectively and enhance their quality of life. By utilizing metronome therapy and auditory cueing through a mobile platform, the app provides personalized treatment regimens that facilitate exercises aimed at improving mobility, speech, and dexterity. Designed by medical professionals, the app seeks to grant users greater independence and control over their symptoms. Operating clinics in Dublin and Harley Street in London, Beats Medical is committed to addressing the mobility challenges associated with Parkinson's disease, aiming to improve the overall well-being of patients and their families through tailored therapeutic solutions.

PolyDev is a limited company set up to bring specialist innovation to the cosmetic contact lens market. It has a core competence in biomedical inks and printing, and has used this expertise to bring the TORIColors lens to market. PolyDev is the manufacturer of TORIColors brand of cosmetic contact lens. They are on sale in the US currently and will be released to other countries as regulatory compliance is achieved.

Signum Surgical Limited is a medical technology company based in Galway, Ireland, founded in 2014 by Eoin Bambury and Moshe Zilversmit. The company specializes in developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the end of the bowel and the skin near the anus. Signum Surgical's primary product is a bio-absorbable implant designed to be used post-surgery, facilitating the closure and healing of the fistula tract. This implant dissolves within the body after treatment and helps prevent reinfection, thereby promoting a faster healing process. The company's focus on addressing the lack of innovation in this area aims to enhance the effectiveness of care for patients suffering from colorectal conditions.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013, specializing in solutions for assessing physical function and preventing falls risk in older adults. The company has developed a patented platform that monitors and identifies mobility impairments by categorizing various mobility parameters, including walking, variability, symmetry, transfers, and turning. By comparing patients' mobility scores against population data based on age and gender, Kinesis Health Technologies provides a comprehensive method for evaluating falls risk and assessing gait, mobility, and frailty in a standardized manner. The team behind Kinesis Health Technologies possesses extensive experience in business, marketing, and technology, supported by 12 years of research conducted in Ireland.

THEYA Healthcare is a multi-award-winning medical device company that specializes in the design and manufacture of innovative post-surgery garments, particularly for women undergoing breast cancer treatment and other cosmetic surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of post-operative patients. Theya Healthcare's flagship product line features bras made from a unique bamboo fabric that is scientifically proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare products experienced significant improvements in body image and health status, along with reduced pain and discomfort compared to competing products. Since its inception, the company has garnered numerous accolades, highlighting its commitment to enhancing the recovery experience for women after surgery.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

SiriusXT Limited is a company that specializes in the development and manufacturing of soft x-ray microscopes, specifically the SXT system. Founded in 2015 and headquartered in Dublin, Ireland, SiriusXT's innovative technology utilizes a vacuum-based laser-produced plasma light source to enable high-resolution imaging of biological samples. The SXT system is designed for researchers in disease research and drug discovery, providing a crucial tool for visualizing the 3D internal structures of cells in their native, fully hydrated state without the need for stains or contrast agents. This capability is essential for understanding disease pathways, protein-drug interactions, and bio-engineering processes. SiriusXT is recognized for offering the world's first high-throughput, benchtop soft x-ray tomography system, allowing users to produce detailed tomographs quickly and efficiently.

Pharmapod Ltd. is a cloud-based technology company headquartered in Dublin, Ireland, with additional offices in London, Canada, and London, United Kingdom. Established in 2010, it specializes in providing innovative incident reporting and learning systems aimed at enhancing patient safety within the pharmacy profession globally. Pharmapod's platform offers a comprehensive suite of compliance software tailored for both hospital and retail pharmacy sectors, enabling pharmacists to effectively record and manage risks to patient safety. The system facilitates structured clinical services and promotes knowledge sharing among professionals, while also supporting compliance with legal and professional standards. By pooling and analyzing patient safety data across various regions, Pharmapod empowers healthcare professionals to identify trends and underlying causes of medication errors, ultimately driving improvements in practice and operational efficiencies.

Adaptics Ltd. provides Drop, an iPad-connected kitchen scale and digital baking assistant for home bakers. Adaptics adds noticeable vitality to employees and organisations and helps them maintain long-term success. They do this by embedding top-quality service provision in vitalising managers, teams and players. Adaptics considers vitality a strategic resource that forms a basis for desired change in society. They have developed a unique integral approach that includes training, coaching, instructions and online tools. Adaptics has the ambition to address vitality at Champions League level, and to set the standard for corporate health in the Netherlands along with its partners and clients.

Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.

Nuritas Ltd., established in 2012 and headquartered in Dublin, Ireland, is a biotechnology company specializing in the discovery of bioactive peptides from food sources using artificial intelligence and genomics. The company's proprietary platform combines computational biology with nutritional science to identify and extract health-benefiting components hidden within food, enabling it to create functional foods and cosmetics. Nuritas collaborates with industry partners to co-develop new ingredients, with applications in human and animal nutrition, beverages, dietary supplements, and cosmetics.

Ace Health Innovations (AHI) is committed to addressing poor patient engagement and is developing a range of innovative and cost-effective patient communication solutions that improves patient outcomes and quality of care. Patient-clinician partnerships are a cornerstone of emerging regulation and reimbursement systems in healthcare. ACE Health is a patient focused company focused specifically on the collection, analysis and secure storage of patient reported data. They help healthcare providers use data such as patient engagement and outcomes during treatment that can be easily incorporated into clinical practice and case management. Through integration with almost any existing electronic health record or case management system they help managers, clinicians and researchers examine aggregate statistics around quality and efficacy.

In Hand Guides Ltd. is a company based in Crosshaven, Ireland, that specializes in creating devices designed to deliver customized audio content. Established in 2005, the company provides a range of audio solutions, including tourism audio players that offer information and promotion for city and conference guides. Their products also serve the retail sector as audio guides or souvenirs, and they cater to event and corporate needs by delivering branding and client information. Additionally, In Hand Guides develops health and lifestyle audio devices aimed at disseminating information on critical health issues, improving compliance, and promoting lifestyle choices. The company further enhances its offerings with audio production services, including voiceover and translation in multiple languages.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's core product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system. Neuromod's mission is to empower patients worldwide, including the 10% of adults affected by chronic tinnitus, by delivering targeted, non-invasive therapies that seamlessly integrate into daily life.

Radisens Diagnostics is focused on developing a digital diagnostic platform that streamlines point-of-care testing for a range of chronic and acute diseases. The company addresses the limitations of existing tests, which often require diverse instruments and do not integrate well with patient health records, resulting in inefficiencies in healthcare delivery. By creating a device capable of performing multiple tests, including those for diabetes, heart disease, hypertension, and chronic kidney conditions, Radisens aims to provide quick and reliable results from just a single drop of blood. The company's roadmap includes the development of additional test panels for various health conditions. By placing these diagnostic devices in general practitioner clinics, emergency rooms, and outpatient departments, Radisens intends to enhance diagnostic capabilities while driving cost savings and enabling performance-based incentives for insurers.

NOvate Medical Technologies is a medical device development company based in New Orleans, dedicated to creating high-quality, low-cost, and sustainable medical products that address pressing global health challenges. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from potential infections. This innovative device aims to significantly reduce maternal and neonatal mortality rates, particularly in developing countries, by enhancing the safety of childbirth and allowing healthcare professionals to manage clots effectively. Through its focus on affordability and sustainability, NOvate Medical Technologies strives to improve healthcare outcomes in underserved communities.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

NOvate Medical Technologies is a medical device development company based in New Orleans, dedicated to creating high-quality, low-cost, and sustainable medical products that address pressing global health challenges. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from potential infections. This innovative device aims to significantly reduce maternal and neonatal mortality rates, particularly in developing countries, by enhancing the safety of childbirth and allowing healthcare professionals to manage clots effectively. Through its focus on affordability and sustainability, NOvate Medical Technologies strives to improve healthcare outcomes in underserved communities.

Cellix Ltd., established in 2004, specializes in the development, manufacturing, and distribution of microfluidic pumping solutions and associated products. Based in Dublin, Ireland, with an additional office in New York, the company serves biology laboratories across academia, government, and the pharmaceutical and biotechnology industries worldwide. Cellix's portfolio includes micro fluidic pumps, biochips mimicking human capillaries, and software for cell analysis. These solutions enable researchers to perform in-vitro assays under physiological conditions, mimicking in-vivo conditions of the blood vessel, and study drug effects on cell activity for various applications such as cardiovascular, oncology, and infectious diseases. The company's products are sold through distributors in Europe and Asia.